An audience with Sir Bruce Keogh KBE

The King's Fund
Event type: 
Board Leadership Programme

About this event

In February 2013, the Secretary of State for Health and the Prime Minister commissioned a review into the quality of care and treatment provided by hospital trusts with persistently high mortality rates. This followed on from the learning from Mid Staffordshire NHS Foundation Trust whose high mortality rates were associated with failures in all three dimensions of quality clinical effectiveness, patient experience and safety as well as failures in professionalism, leadership and governance.

Sir Bruce will outline his findings from the review and open up the debate into the role of the board, and specifically what the non-executive directors of both provider and commissioning organisations should be doing to monitor patient outcomes, use data to drive quality improvement and genuinely listen to the views of patients and staff.

The speaker

Sir Bruce Keogh KBE

Professor Sir Bruce Keogh was deputy CMO and Medical Director for England's National Health Service from November 2007 to March 2013. He subsequently became the National Medical Director for NHS England, where he has responsibility for the first three domains of the NHS Outcomes Framework.: reducing premature mortality, improving the lives of people with long-term conditions and improving acute care. In addition, he is responsible for specialised commissioning and innovation. He is the senior responsible officer for revalidation of doctors in England.

Previously, Sir Bruce was an associate medical director at University Hospital Birmingham prior to becoming Director of Surgery and The Heart Hospital, and Professor of Cardiac Surgery at University College London. In a distinguished career in surgery, he has been the President of the Society for Cardiothoracic Surgery and a Director of the US Society of Thoracic Surgeons. He has served as a commissioner on the Commission for Health Improvement and the Healthcare Commission and was knighted for his services to medicine in 2003.